STAT

A stubborn medical mystery: Was pandemic flu vaccine tied to an increase in narcolepsy cases?

Scientists have been trying to understand why some countries saw a rise in narcolepsy cases — and whether the spike was tied to the 2009 influenza pandemic.
People sit in the waiting room at a Mexico City hospital to be checked for flu-like symptoms during the 2009 flu pandemic.

Nearly a decade on from the 2009 influenza pandemic, scientists are still trying to solve what is proving to be an intractable medical mystery: Did some of the vaccines used to protect against the new flu virus trigger an increase in narcolepsy cases?

A major attempt to unravel the mystery — a study that’s still in the publication pipeline — did not find evidence that vaccines containing a boosting compound called an adjuvant sparked a rise in cases of narcolepsy, a serious but rare sleep disorder.

But absence of evidence is not evidence of absence, as scientists are quick to point out. Among them would be the researcher who led the effort.

Dr. Steven Black believes that the SOMNIA study, for a variety of reasons, was unable to crack the puzzle. And he thinks it’s critical to keep looking for the answer, because the use of adjuvants will likely be necessary the next time a severe flu pandemic hits — both to make the vaccine more potent and to stretch limited supplies.

“We don’t know if there’s an association or not for sure. I believe there is, even though the study I did showed that there wasn’t,” Black, an infectious diseases expert at Cincinnati Children’s Hospital, told STAT.

“The upshot of this is that this is a complicated story,” he said. “But I think the real upshot

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks